Victoria Everton, MD
Undersea and Hyperbaric Medicine · Shreveport, LANPI 1952339038
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $683 and has fallen 70.3% since, to $203 in 2025.
Across 110 payments — averaging $18.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$482
- Paratek Pharmaceuticals, Inc.$275
- KCI USA, Inc.$185
- AbbVie$172
- Organogenesis Inc.$154
- Integra Lifesciences Corporation$151
- plus $620 from 13 others
What the payments were for
- Food & beverage$2,037100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 28 | $482 |
| Paratek Pharmaceuticals, Inc. | 15 | $275 |
| KCI USA, Inc. | 10 | $185 |
| AbbVie(2 entities) | 10 | $172 |
| Organogenesis Inc. | 8 | $154 |
| Integra Lifesciences Corporation | 8 | $151 |
| TEI Medical Inc. | 4 | $126 |
| Next Science LLC | 6 | $109 |
| Tactile Systems Technology Inc | 5 | $100 |
| Kerecis Limited | 4 | $97 |
| Biowound Solutions, Inc. | 3 | $33 |
| Melinta Therapeutics, LLC | 2 | $31 |
| Molnlycke Health Care US, LLC | 1 | $24 |
| Convatec Inc. | 1 | $21 |
| Krystal Biotech Inc | 1 | $19 |
| Nabriva Therapeutics, PLC | 1 | $17 |
| Medela LLC | 1 | $16 |
| Solventum Corporation | 1 | $15 |
| Merck | 1 | $11 |
How this compares
Too few undersea and hyperbaric medicine providers in Louisianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Linezolid | 14 | $2,119 |
| Doxycycline Hyclate | 41 | $424 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 49 | $234 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $227 |
| NystopNystatin | 24 | $175 |
| Ciprofloxacin Hcl | 35 | $144 |
| Triamcinolone Acetonide | 27 | $144 |
| Nystatin | 20 | $129 |
| Mupirocin | 16 | $125 |
| Sodium Chloride0.9 % Sodium Chloride | 19 | $96 |
| Levofloxacin | 18 | $65 |
Paid to pharmacies, not to this prescriber.
Other undersea and hyperbaric medicine in Shreveport
- Gary MazzantiShreveport$381
- Micah SiegelKenner$34K
- Stephen AgansMarrero$3K
- Christine CaoNew Orleans$976
- Sarah ParksHarvey$884
- John KesselsCovington$229
- Steven MehaffeyNew Orleans$185
- Halsey WyattNew Orleans$95
- Paul HarchNew Orleans$73
- Kristi RayHarvey$38
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.